Home / Cardiovascular system / Olmesartan Medoxomil and Amlodipine
ATC C09DB02 · Agents Acting On The Renin-Angiotensin System
Olmesartan Medoxomil and Amlodipine shortage
As of 31 Oct 2026, Olmesartan Medoxomil and Amlodipine has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 11 products.
Countries3/5
Products11packs or presentations
Short since21 Aug 20233.2 years ago
Earliest return12 Nov 2026company estimate
No return date5products
Main reasonManufacturing problem
Timeline
ItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | OLMESARTAN MEDOXOMIL E AMLODIPINA ZENTIVA | ZENTIVA ITALIA S.R.L. | 21 Aug 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL E AMLODIPINA ZENTIVA | ZENTIVA ITALIA S.R.L. | 23 Feb 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL E AMLODIPINA ZENTIVA | ZENTIVA ITALIA S.R.L. | 17 Apr 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL E AMLODIPINA ACCORD | ACCORD HEALTHCARE, S.L.U. | 24 Apr 2026 | not given | Increased demand Elevata richiesta |
| IT | SEVIKAR | DAIICHI SANKYO ITALIA S.P.A. | 1 Jul 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | OLMESARTAN MEDOXOMIL E AMLODIPINA TEVA | TEVA B.V. | 3 Aug 2026 | 30 Nov 2026 | Manufacturing problem Problemi produttivi (carenza relativa solo al canale retail) |
| ES | SEVIKAR 20 mg/5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | Daiichi Sankyo Espana S.A. | 26 Aug 2026 | 26 Dec 2026 | Not stated |
| BE | Sevikar 40 mg - 5 mg film-coat. tabl. 28 | Daiichi Sankyo Belgium | 19 Jun 2026 | 29 Jan 2027 | Manufacturing problem Delay in production |
| BE | Forzaten 20 mg - 5 mg (PI Pharma) film-coat. tabl. 98 | PI Pharma | 6 Aug 2026 | 30 Nov 2026 | Other Other reason |
| BE | Olmesartan/Amlodipine EG 20 mg - 5 mg film-coat. tabl. 100 | EG | 13 Oct 2026 | 12 Nov 2026 | Manufacturing problem Delay in production |
| BE | Sevikar 40 mg - 10 mg film-coat. tabl. 98 announced | Daiichi Sankyo Belgium | 5 Nov 2026 | 20 Nov 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.